PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
07-Jun-2022 4P-Pharma and Delta 4 Join Forces to Find and Develop Treatments for a Rare Autoimmune Chronic Liver Disease 4P-Pharma and Delta 4
07-Jun-2022 EVERSANA and Limitless Minds Advance Pharmaceutical Sales Performance with New Cognitive & Behavioral Training Solution EVERSANA
07-Jun-2022 Newron presents encouraging interim results for evenamide in patients with Treatment-Resistant Schizophrenia (TRS) at the 33rd CINP Hybrid World Congress of Neuropsychopharmacology Newron Pharmaceuticals S.p.A.
07-Jun-2022 AEVIS VICTORIA SA takes a stake in the Well digital health platform AEVIS VICTORIA SA
06-Jun-2022 Enhertu reduced the risk of disease progression or death by 50% vs. chemotherapy in patients with HER2-low metastatic breast cancer with HR-positive and HR-negative disease AstraZeneca
03-Jun-2022 Biophytis: Convening of Another Combined General Meeting at a Later Date Biophytis
03-Jun-2022 Coriolis Pharma Invests in Growth by Creating a New Campus in Martinsried-Munich B3C newswire
02-Jun-2022 ProBioGen Grows by 50 Percent in Last Two Years B3C newswire
02-Jun-2022 Moderna and the European Commission Agree on Amendment to COVID-19 Vaccine Supply Agreement Moderna, Inc.
02-Jun-2022 4P-Pharma and Delta 4 Join Forces to Find and Develop Treatments for a Rare Autoimmune Chronic Liver Disease B3C newswire
02-Jun-2022 Original-Research: Haemato AG (von First Berlin Equity Research GmbH) Haemato AG
02-Jun-2022 Original-Research: HAEMATO AG (von GBC AG) HAEMATO AG
02-Jun-2022 MPH Health Care AG: Q1 result 2022 MPH Health Care AG
02-Jun-2022 Navigo Proteins Announces Launch of an Exclusive Affinity Resin for the Capture of gp64 B3C newswire
02-Jun-2022 Kuros Biosciences: Completion of the acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals triggers a $5 million milestone payment Kuros Biosciences AG
01-Jun-2022 Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 2.17 per share Dermapharm Holding SE
01-Jun-2022 Almac Discovery nominates a first candidate molecule from its Protein Drug Conjugate (PDC) Platform to progress into pre-clinical development Almac Discovery
01-Jun-2022 Vetter Publishes First Sustainability Report B3C newswire
01-Jun-2022 ProQR Announces Annual General Meeting of Shareholders and Provides Leadership Updates ProQR Therapeutics N.V.
01-Jun-2022 HUTCHMED Announces TAZVERIK® Approved to be Used in Hainan Pilot Zone in China HUTCHMED